uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Correlation of sensivity in vitro of human leukemia cells and systemic exposure at maximal tolerable dose (MTD) in man for cell cycle phase specific (type 2) anticancer drugs.
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Medical Sciences. (Klinisk farmakologi, R Larsson)
Department of Oncology, Radiology and Clinical Immunology.
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Medical Sciences. (Klinisk farmakologi, R Larsson)
1996 (English)In: Anticancer Drugs, Vol. 7, 105- p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
1996. Vol. 7, 105- p.
Identifiers
URN: urn:nbn:se:uu:diva-54713OAI: oai:DiVA.org:uu-54713DiVA: diva2:82622
Available from: 2008-10-17 Created: 2008-10-17 Last updated: 2011-01-15

Open Access in DiVA

No full text

By organisation
Department of Medical SciencesDepartment of Oncology, Radiology and Clinical Immunology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 298 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf